3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
21
Rectal Neoplasms
18
Colonic Neoplasms
18
Stomach Neoplasms
13
Gastrointestinal Stromal Tumors
5
Carcinoma, Hepatocellular
5
Pancreatic Neoplasms
3
Liver Neoplasms
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Urinary Incontinence
1
Surgical Wound Infection
1
Sexual Dysfunction, Physiological
1
Robotic
1
Pancreatic Neuroendocrine Tumors
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphatic Metastasis
1
Locally Advanced Pancreatic Adenocarcinoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Sorafenib
5
lenvatinib
3
sintilimab
2
pembrolizumab
2
halofantrine
2
camrelizumab
2
atezolizumab
2
Immunotherapy
2
Blood Specimen Collection
2
Bevacizumab
2
Antibodies
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
titanium silicide
1
tislelizumab
1
linifanib
1
genexol-PM
1
gadolinium ethoxybenzyl DTPA
1
fluorocholine
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
bavituximab
1
avelumab
1
User-Centered Design
1
Sunitinib
1
Sufentanil
1
Standard of Care
1
Shadowing Technique, Histology
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Diseases
×
Laparoscopy
×
Gastrointestinal
×
Clear all
NCT01567631
2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA
Unknown
80 enrolled